skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Selenium and tellurium as carbon substitutes

Conference ·
OSTI ID:5522590

This review has summarized structure-activity studies with /sup 75/Se- and /sup 123m/Te-labeled radiopharmaceuticals in which the selenium or tellurium heteroatom has been inserted between carbon-carbon bonds. The agents that have been investigated in most detail include steroids for adrenal imaging and long-chain fatty acids, and a variety of other unique agents have also been studied. Because of the great versatility of the organic chemistry of selenium and tellurium, there is continuing interest in the preparation of radiopharmaceuticals labeled with /sup 75/Se, /sup 73/Se, and /sup 123m/Te. There are two important factors which will determine the extent of future interest in such agents. These include the necessity of a decrease in the cost of highly enriched /sup 122/Te to make the reactor production of /sup 123m/Te cost effective. In addition, the potential preparation of large amounts of /sup 73/Se should stimulate the development of /sup 73/Se-labeled radiopharmaceuticals.

Research Organization:
Oak Ridge National Lab., TN (USA)
Sponsoring Organization:
USDOE
DOE Contract Number:
W-7405-ENG-26
OSTI ID:
5522590
Report Number(s):
CONF-800336-1; TRN: 80-007534
Resource Relation:
Conference: Radiopharmaceuticals: structure activity relationships symposium, Hartford, CT, USA, 21 Mar 1980
Country of Publication:
United States
Language:
English